AliMahdaviMD

Obstetrics & Gynecology • York, PA

Gynecologic Oncology

Physician

Join to view full profile

Dr. Mahdavi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mahdavi's full profile

Already have an account?

Office
25 Monument Rd
Ste 295
York, PA 17403
Phone+1 717-851-6120

Fax+1 717-851-6969

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Gynecologic Oncology, 2002 - 2005
Ascension Providence/MSUCHMResidency, Obstetrics and Gynecology, 1996 - 2000
Tehran University of Medical Sciences School of MedicineClass of 1992

Certifications & Licensure

CA State Medical License 2004 - 2025
MD State Medical License 2022 - 2025
PA State Medical License 2024 - 2024
IN State Medical License 2021 - 2023
WI State Medical License 2010 - 2023
IL State Medical License 2016 - 2020
NY State Medical License 2004 - 2006
TN State Medical License 2001 - 2005
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29
Active, not recruiting
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Start of enrollment: 2014 Feb 14
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

57 citations
Induction of ovulation and ovarian cancer : a critical review of the literature
Ali Mahdavi, Tanja Pejovic, Farr Nezhat
Fertility and Sterility. 2006-04-01
7 citations
The outcome of Iranian children on continuous ambulatory peritoneal dialysis: the first report of Iranian National Registry.
Nakysa Hooman, S T Esfahani, Masoumeh Mohkam, Ali Derakhshan, Alaleh Gheissari
Archives of Iranian Medicine. 2009-01-01
2 citations
Comparative restriction enzyme mapping of Campylobacter jejuni isolates from turkeys and broilers based on flaA flagellar gene using HpyF3I endonuclease
Elham Atefi Tabar, Hamid Staji, Ali Mahdavi
Folia Microbiologica. 2019-03-01

Press Mentions

7 Causes of Ovarian Cancer Doctors Want You to Know AboutSeptember 17th, 2018